Title : Effect of Trelagliptin on Quality of Life in Patients with Type 2 Diabetes Mellitus: Study Protocol.

Pub. Date : 2017 Dec

PMID : 29076039






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 This study has been proposed to assess the reduction in treatment burden during 12 weeks" administration of trelagliptin, a weekly dosing dipeptidyl peptidase-4 (DPP-4) inhibitor, compared with a daily dosing DPP-4 inhibitor in patients with type 2 diabetes. trelagliptin dipeptidyl peptidase 4 Homo sapiens
2 This study has been proposed to assess the reduction in treatment burden during 12 weeks" administration of trelagliptin, a weekly dosing dipeptidyl peptidase-4 (DPP-4) inhibitor, compared with a daily dosing DPP-4 inhibitor in patients with type 2 diabetes. trelagliptin dipeptidyl peptidase 4 Homo sapiens